Chao Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chao Peng has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Christopher K. Williams
Section of Neuropathology, Department of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, Los Angeles, CA, USA
3 shared publicationsHarry V. Vinters
Section of Neuropathology, Department of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, Los Angeles, CA, USA; Department of Neurology, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, Los Angeles, CA, USA; Brain Research Institute, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, Los Angeles, CA, USA
3 shared publications- Shujing Zhang
Department of Neurology, David Geffen School of Medicine, University of California—Los Angeles, Los Angeles, USA
3 shared publications - Virginia M.-Y. Lee
Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute on Aging, University of Pennsylvania School of Medicine
3 shared publications - Ashish Raj
University of California, San Francisco
2 shared publications Benjamin A. Garcia
Department of Biochemistry and Molecular Biophysics, Washington University St Louis, St Louis, USA
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Elsevier in Neurobiology of Aging
- Vol. 169, 110-124
Neuropathology of centenarians and supercentenarians: An autopsy study
- 16 September 2026
- Published by Elsevier in Neurobiology of Aging
- Vol. 169, 110-124
Open AccessNeuropathology of centenarians and supercentenarians: An autopsy study
- Open Access
- 28 May 2025
- Published by Wiley in Advanced Science
- Vol. 12 (25) , e2413052
Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading
Previous studies have suggested that pathological α‐synuclein (α‐Syn) mainly transmits along the neuronal network, but several key questions remain unanswered: 1) How many and which connections in the connectome are necessary for predicting the progression of pathological α‐Syn? 2) How to identify risk genes that affect pathology spreading functioning at presynaptic or postsynaptic regions, and are these genes enriched in different cell types? Here, these questions are addressed with novel mathematical models. Strikingly, the spreading of pathological α‐Syn is predominantly determined by the key subnetworks composed of only 2% of the strongest connections in the connectome. Genes associated with the selective vulnerability of brain regions to pathological α‐Syn transmission are further analyzed to distinguish those functioning at presynaptic versus postsynaptic regions. Those risk genes are significantly enriched in microglial cells of presynaptic regions and neurons of postsynaptic regions. Gene regulatory network analyses are then conducted to identify “key drivers” of genes responsible for selective vulnerability and overlapping with Parkinson's disease risk genes. By identifying and discriminating between key gene mediators of transmission operating at presynaptic and postsynaptic regions, this study has demonstrated for the first time that these are functionally distinct processes.
- 28 May 2025
- Published by Wiley in Advanced Science
- Vol. 12 (25) , e2413052
Open AccessKey Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading
Previous studies have suggested that pathological α‐synuclein (α‐Syn) mainly transmits along the neuronal network, but several key questions remain unanswered: 1) How many and which connections in the connectome are necessary for predicting the progression of pathological α‐Syn? 2) How to identify risk genes that affect pathology spreading functioning at presynaptic or postsynaptic regions, and are these genes enriched in different cell types? Here, these questions are addressed with novel mathematical models. Strikingly, the spreading of pathological α‐Syn is predominantly determined by the key subnetworks composed of only 2% of the strongest connections in the connectome. Genes associated with the selective vulnerability of brain regions to pathological α‐Syn transmission are further analyzed to distinguish those functioning at presynaptic versus postsynaptic regions. Those risk genes are significantly enriched in microglial cells of presynaptic regions and neurons of postsynaptic regions. Gene regulatory network analyses are then conducted to identify “key drivers” of genes responsible for selective vulnerability and overlapping with Parkinson's disease risk genes. By identifying and discriminating between key gene mediators of transmission operating at presynaptic and postsynaptic regions, this study has demonstrated for the first time that these are functionally distinct processes.
- Open Access
Distinguish risk genes functioning at presynaptic or postsynaptic regions and key connectomes associated with pathological α-synuclein spreading
Previous studies have suggested that pathological α-synuclein (α-Syn) mainly transmits along the neuronal network, but several key questions remain unanswered: (1) How many and which connections in the connectome are necessary for predicting the progression of pathological α-Syn? (2) How to identify risk gene that affects pathology spreading functioning at presynaptic or postsynaptic regions, and are these genes enriched in different cell types? Here, we addressed these key questions with novel mathematical models. Strikingly, the spreading of pathological α-Syn is predominantly determined by the key subnetworks composed of only 2% of the strongest connections in the connectome. We further explored the genes that are responsible for the selective vulnerability of different brain regions to transmission to distinguish the genes that play roles in presynaptic from those in postsynaptic regions. Those risk genes were significantly enriched in microglial cells of presynaptic regions and neurons of postsynaptic regions. Gene regulatory network analyses were then conducted to identify ‘key drivers’ of genes responsible for selective vulnerability and overlapping with Parkinson’s disease risk genes. By identifying and discriminating between key gene mediators of transmission operating at presynaptic and postsynaptic regions, our study has demonstrated for the first time that these are functionally distinct processes.
Open AccessDistinguish risk genes functioning at presynaptic or postsynaptic regions and key connectomes associated with pathological α-synuclein spreading
Previous studies have suggested that pathological α-synuclein (α-Syn) mainly transmits along the neuronal network, but several key questions remain unanswered: (1) How many and which connections in the connectome are necessary for predicting the progression of pathological α-Syn? (2) How to identify risk gene that affects pathology spreading functioning at presynaptic or postsynaptic regions, and are these genes enriched in different cell types? Here, we addressed these key questions with novel mathematical models. Strikingly, the spreading of pathological α-Syn is predominantly determined by the key subnetworks composed of only 2% of the strongest connections in the connectome. We further explored the genes that are responsible for the selective vulnerability of different brain regions to transmission to distinguish the genes that play roles in presynaptic from those in postsynaptic regions. Those risk genes were significantly enriched in microglial cells of presynaptic regions and neurons of postsynaptic regions. Gene regulatory network analyses were then conducted to identify ‘key drivers’ of genes responsible for selective vulnerability and overlapping with Parkinson’s disease risk genes. By identifying and discriminating between key gene mediators of transmission operating at presynaptic and postsynaptic regions, our study has demonstrated for the first time that these are functionally distinct processes.
- Open Access
- 25 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108351
Structural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons
- 25 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108351
Open AccessStructural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons
- Open Access
- 9 October 2023
- Published by Springer Nature in Nature Neuroscience
- Vol. 26 (12) , 2250
Author Correction: Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein
- 9 October 2023
- Published by Springer Nature in Nature Neuroscience
- Vol. 26 (12) , 2250
Open AccessAuthor Correction: Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein
- Open Access
- 22 September 2023
- Published by Medknow in Neural Regeneration Research
- Vol. 19 (5) , 959-960
Soluble alpha-synuclein post-translational modifications: unexpected regulators of pathological alpha-synuclein amplification
- 22 September 2023
- Published by Medknow in Neural Regeneration Research
- Vol. 19 (5) , 959-960
Open AccessSoluble alpha-synuclein post-translational modifications: unexpected regulators of pathological alpha-synuclein amplification
- Top Cited Papers
- 23 January 2023
- Published by Springer Nature in Nature Neuroscience
- Vol. 26 (2) , 213-225
Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein
Cell-to-cell transmission and subsequent amplification of pathological proteins promote neurodegenerative disease progression. Most research on this has focused on pathological protein seeds, but how their normal counterparts, which are converted to pathological forms during transmission, regulate transmission is less understood. Here we show in cultured cells that phosphorylation of soluble, nonpathological α-synuclein (α-Syn) at previously identified sites dramatically affects the amplification of pathological α-Syn, which underlies Parkinsonʼs disease and other α-synucleinopathies, in a conformation- and phosphorylation site-specific manner. We performed LC–MS/MS analyses on soluble α-Syn purified from Parkinsonʼs disease and other α-synucleinopathies, identifying many new α-Syn post-translational modifications (PTMs). In addition to phosphorylation, acetylation of soluble α-Syn also modified pathological α-Syn transmission in a site- and conformation-specific manner. Moreover, phosphorylation of soluble α-Syn could modulate the seeding properties of pathological α-Syn. Our study represents the first systematic analysis how of soluble α-Syn PTMs affect the spreading and amplification of pathological α-Syn, which may affect disease progression.
- 23 January 2023
- Published by Springer Nature in Nature Neuroscience
- Vol. 26 (2) , 213-225
Top Cited PapersPost-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein
Cell-to-cell transmission and subsequent amplification of pathological proteins promote neurodegenerative disease progression. Most research on this has focused on pathological protein seeds, but how their normal counterparts, which are converted to pathological forms during transmission, regulate transmission is less understood. Here we show in cultured cells that phosphorylation of soluble, nonpathological α-synuclein (α-Syn) at previously identified sites dramatically affects the amplification of pathological α-Syn, which underlies Parkinsonʼs disease and other α-synucleinopathies, in a conformation- and phosphorylation site-specific manner. We performed LC–MS/MS analyses on soluble α-Syn purified from Parkinsonʼs disease and other α-synucleinopathies, identifying many new α-Syn post-translational modifications (PTMs). In addition to phosphorylation, acetylation of soluble α-Syn also modified pathological α-Syn transmission in a site- and conformation-specific manner. Moreover, phosphorylation of soluble α-Syn could modulate the seeding properties of pathological α-Syn. Our study represents the first systematic analysis how of soluble α-Syn PTMs affect the spreading and amplification of pathological α-Syn, which may affect disease progression.
- Open Access
- 26 November 2022
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 17 (1) , 1-3
LRP1: a novel receptor for the transmission of pathological α-Synuclein
- 26 November 2022
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 17 (1) , 1-3
Open AccessLRP1: a novel receptor for the transmission of pathological α-Synuclein
- Open Access
Characterizing relevant microRNA editing sites in Parkinson’s disease
MicroRNAs (miRNAs) are extensively edited in human brains. However, the functional relevance of miRNA editome is largely unknown in Parkinson’s disease (PD). By analyzed small RNA sequencing profiles of brain tissues of 43 PD patients and 88 normal controls, we totally identified 421 miRNA editing sites with significantly different editing levels in prefrontal cortices of PD patients (PD-PC). A-to-I edited miR-497-5p has significantly higher expression levels in PD-PC compared to normal controls and directly represses OPA1 and VAPB, which potentially contributes to the progressive neurodegeneration of PD patients. These results provide new insights into mechanistic understanding, novel diagnostic and therapeutic clues of PD.
Open AccessCharacterizing relevant microRNA editing sites in Parkinson’s disease
MicroRNAs (miRNAs) are extensively edited in human brains. However, the functional relevance of miRNA editome is largely unknown in Parkinson’s disease (PD). By analyzed small RNA sequencing profiles of brain tissues of 43 PD patients and 88 normal controls, we totally identified 421 miRNA editing sites with significantly different editing levels in prefrontal cortices of PD patients (PD-PC). A-to-I edited miR-497-5p has significantly higher expression levels in PD-PC compared to normal controls and directly represses OPA1 and VAPB, which potentially contributes to the progressive neurodegeneration of PD patients. These results provide new insights into mechanistic understanding, novel diagnostic and therapeutic clues of PD.
- 1 January 2018
- Published by Elsevier in Neurobiology of Disease
- Vol. 109 (Pt B) , 209-218
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
- 1 January 2018
- Published by Elsevier in Neurobiology of Disease
- Vol. 109 (Pt B) , 209-218
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies